The fibroid growth study: Determinants of therapeutic intervention

Journal of Women's Health

Volumn 18, Issue 5, 2009, Pages 725-732

  Davis, Barbara J ^a,b   Haneke, Karen E ^c,d   Miner, Kelly ^a,e   Kowalik, Ania ^f,g   Barrett, J Carl ^e,h   Peddada, Shyamal ^a   Baird, Donna Day ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c INTEGRATED LABORATORY SYSTEMS   (United States)

^d FAMILY HEALTH INTERNATIONAL   (United States)

^e NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST;

ADULT; AFRICAN AMERICAN; ARTICLE; BLEEDING; BLOOD SAMPLING; CONTROLLED STUDY; EUROPEAN AMERICAN; FEMALE; FIBROID GROWTH STUDY; GROUPS BY AGE; HISTORY OF MEDICINE; HUMAN; HYSTERECTOMY; INTERVENTION STUDY; LEIOMYOMA; MAJOR CLINICAL STUDY; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN; PHYSICAL EXAMINATION; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; RACE; SCORING SYSTEM; STRESS; SYMPTOM; TELEPHONE; UTERUS MYOMA; VALIDATION STUDY; WILCOXON SIGNED RANKS TEST;

ADULT; DECISION MAKING; EMBOLIZATION, THERAPEUTIC; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYSTERECTOMY; LEIOMYOMA; MIDDLE AGED; PELVIC PAIN; TREATMENT OUTCOME; UTERINE HEMORRHAGE; UTERINE NEOPLASMS; WOMEN'S HEALTH; YOUNG ADULT;

EID: 68349113646     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2008.0903     Document Type: Article

References (7)

1. Stewart EA. Uterine fibroids. Lancet 2001;357:293-298.
2. Flynn M, Jamison M, Datta S, Myers E. Heath care resource use for uterine fibroid tumors in the United States. Am J Obstet Gynecol 2006;195:955-964.
3. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Gu-zinski GM. Uterine leiomyomas. Racial differences in severity, symptoms, and age at diagnosis. J Reprod Med 1996; 41:483.
4. Carlson KJ, Miller BA, Fowler FJ Jr. The Maine Women's Health Study: II. Outcomes of nonsurgical management of leiomyomas, abnormal bleeding, and chronic pelvic pain. Obstet Gynecol 1994;83:566-572.
5. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premeno-pausal women by age and race. Obstet Gynecol 1997;90: 967-973.
6. Weber AM, Mitchinson AR, Gidwani GP, Mascha E, Walters MD. Uterine myomas and factors associated with hysterectomy in premenopausal women. Am J Obstet Gynecol 1997; 176:1213-1219.
7. Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. Am J Obstet Gynecol 2003;188:100-107.